• Exchange: EN Paris
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

TNG:FP

8.3800 EUR 0.3200 3.68%

As of 07:59:23 ET on 10/01/2014.

Snapshot for Transgene SA (TNG)

Open: 8.7000 Day's Range: 8.3800 - 8.8400 Volume: 85,352
Previous Close: 8.7000 52wk Range: 7.0900 - 13.7100 1-Yr Rtn: -12.38%

Stock Chart for TNG

No chart data available.
  • TNG:FP 8.3800
  • 1D
  • 1M
  • 1Y
8.7000
Interactive TNG Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TNG

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. CAC -
Earnings Per Share (EUR) (ttm) -1.2419
Est. EPS (EUR) (12/2014) -1.2960
Est. PEG Ratio -
Market Cap (M EUR) 325.24
Shares Outstanding (M) 38.44
30 Day Average Volume 66,411
Price/Book (mrq) 3.4179
Price/Sale (ttm) 77.7032
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TNG

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for TNG

Transgene S.A. is a biotechnology company. The Company develops vaccines against cancer and infectious diseases. Transgene has products under development for lung, kidney, prostate and colorectal cancers, cutaneous T-cell lymphoma, hepatitis C, malignant melanoma, and muscular dystrophy.

Philippe ArchinardChairman/CEOStephane BoisselExecutive Vice President
Laurence BertaudDir:Human ResourcesNathalie AddaDir:Regulatory Affairs
More Company Profile & Key Executives for TNG

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil